Background: Limited data exist on the significance of acute cerebral microinfarcts (A-CMIs) in the context of acute ischemic stroke (AIS). We aimed to determine the profile and prognostic significance of A-CMIs on magnetic resonance imaging (MRI) in patients presenting with AIS. Methods: A prospective single-center series of patients with AIS who had 3T MRIs between March 2013 and December 2019. The presence, number, and location of A-CMIs on diffusion-weighted imaging, and markers of cerebral small vessel disease (CSVD), macroinfarcts features, and etiology were classified as cardioembolism (CE) or large artery atherosclerosis (LAA) or none. Results: Among 273 patients, A-CMIs were detected in 130 patients (47.6%), of whom cortical A-CMIs were found in 95 (73.0%) patients. Patients with A-CMIs were significantly older, less likely to have diabetes mellitus, and more likely to have atrial fibrillation and an embolic source (CE or LAA) compared to other patients. Patients with A-CMI had a higher frequency of macroinfarcts (diameter >20 mm), more often multiple and distributed in single or multiple vessel territories than other patients. An embolic source (LAA or CE) was independently associated with cortical A-CMIs (LAA adjusted odds ratio [aOR] 4.0 95% confidence interval [CI] 1.6–9.5; CE aOR 2.5, 95% CI 1.1–5.6), whereas lacunes were independently related to subcortical A-CMIs (aOR 2.6, 95% CI 1.2–5.8). Conclusions: We have shown A-CMIs occur in cortical and subcortical regions in nearly half of AIS patients, where microembolism and CSVD are, respectively, the key presumed etiological mechanism.

1.
van Veluw
SJ
,
Shih
AY
,
Smith
EE
,
Chen
C
,
Schneider
JA
,
Wardlaw
JM
,
Detection, risk factors, and functional consequences of cerebral microinfarcts
.
Lancet Neurol
.
2017
;
16
(
9
):
730
40
. .
2.
Brundel
M
,
de Bresser
J
,
van Dillen
JJ
,
Kappelle
LJ
,
Biessels
GJ
.
Cerebral microinfarcts: a systematic review of neuropathological studies
.
J Cereb Blood Flow Metab
.
2012
;
32
(
3
):
425
36
. .
3.
Sonnen
JA
,
Larson
EB
,
Crane
PK
,
Haneuse
S
,
Li
G
,
Schellenberg
GD
,
Pathological correlates of dementia in a longitudinal, population-based sample of aging
.
Ann Neurol
.
2007
;
62
(
4
):
406
13
. .
4.
Smith
EE
,
Schneider
JA
,
Wardlaw
JM
,
Greenberg
SM
.
Cerebral microinfarcts: the invisible lesions
.
Lancet Neurol
.
2012
;
11
(
3
):
272
82
. .
5.
Fu
R
,
Wang
Y
,
Wang
Y
,
Liu
L
,
Zhao
X
,
Wang
DZ
,
The development of cortical microinfarcts is associated with intracranial atherosclerosis: data from the Chinese intracranial atherosclerosis study
.
J Stroke Cerebrovasc Dis
.
2015
;
24
(
11
):
2447
54
. .
6.
Wei
Y
,
Pu
Y
,
Pan
Y
,
Nie
X
,
Duan
W
,
Liu
D
,
Cortical microinfarcts associated with worse outcomes in patients with acute ischemic stroke receiving endovascular treatment
.
Stroke
.
2020
;
51
(
9
):
2742
51
. .
7.
Sagnier
S
,
Okubo
G
,
Catheline
G
,
Munsch
F
,
Bigourdan
A
,
Debruxelles
S
,
Chronic cortical cerebral microinfarcts slow down cognitive recovery after acute ischemic stroke
.
Stroke
.
2019
;
50
(
6
):
1430
6
. .
8.
Lansberg
MG
,
Thijs
VN
,
O’Brien
MW
,
Ali
JO
,
de Crespigny
AJ
,
Tong
DC
,
Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke
.
AJNR Am J Neuroradiol
.
2001
;
22
(
4
):
637
44
.
9.
Arvanitakis
Z
,
Capuano
AW
,
Leurgans
SE
,
Buchman
AS
,
Bennett
DA
,
Schneider
JA
.
The relationship of cerebral vessel pathology to brain microinfarcts
.
Brain Pathol
.
2017
;
27
(
1
):
77
85
. .
10.
van Dalen
JW
,
Scuric
EE
,
van Veluw
SJ
,
Caan
MW
,
Nederveen
AJ
,
Biessels
GJ
,
Cortical microinfarcts detected in vivo on 3 Tesla MRI: clinical and radiological correlates
.
Stroke
.
2015
;
46
(
1
):
255
7
. .
11.
Hilal
S
,
Sikking
E
,
Shaik
MA
,
Chan
QL
,
van Veluw
SJ
,
Vrooman
H
,
Cortical cerebral microinfarcts on 3T MRI: a novel marker of cerebrovascular disease
.
Neurology
.
2016
;
87
(
15
):
1583
90
. .
12.
Wang
Z
,
van Veluw
SJ
,
Wong
A
,
Liu
W
,
Shi
L
,
Yang
J
,
Risk factors and cognitive relevance of cortical cerebral microinfarcts in patients with ischemic stroke or transient ischemic attack
.
Stroke
.
2016
;
47
(
10
):
2450
5
. .
13.
Liu
J
,
Zheng
L
,
Cheng
Y
,
Zhang
S
,
Wu
B
,
Wang
D
,
Trends in outcomes of patients with ischemic stroke treated between 2002 and 2016: insights from a Chinese Cohort
.
Circ Cardiovasc Qual Outcomes
.
2019
;
12
(
12
):
e005610
. .
14.
Liu
J
,
Wang
Y
,
Guo
W
,
Cheng
Y
,
Zhang
S
,
Wu
B
,
Temporal trends of atrial fibrillation and/or rheumatic heart disease-related ischemic stroke, and anticoagulant use in Chinese population: an 8-year study
.
Int J Cardiol
.
2021
;
322
:
258
64
. .
15.
Oliveira-Filho
J
,
Ay
H
,
Shoamanesh
A
,
Park
KY
,
Avery
R
,
Sorgun
M
,
Incidence and etiology of microinfarcts in patients with ischemic stroke
.
J Neuroimaging
.
2018
;
28
(
4
):
406
11
. .
16.
Adams
HP
 Jr
,
Bendixen
BH
,
Kappelle
LJ
,
Biller
J
,
Love
BB
,
Gordon
DL
,
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment
.
Stroke
.
1993
;
24
(
1
):
35
41
. .
17.
Ay
H
,
Benner
T
,
Arsava
EM
,
Furie
KL
,
Singhal
AB
,
Jensen
MB
,
A computerized algorithm for etiologic classification of ischemic stroke: the causative classification of stroke system
.
Stroke
.
2007
;
38
(
11
):
2979
84
. .
18.
Wardlaw
JM
,
Smith
EE
,
Biessels
GJ
,
Cordonnier
C
,
Fazekas
F
,
Frayne
R
,
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
.
Lancet Neurol
.
2013
;
12
(
8
):
822
38
. .
19.
Leng
X
,
Fang
H
,
Pu
Y
,
Zou
X
,
Pan
Y
,
Soo
YOY
,
Cortical microinfarcts in patients with middle cerebral artery stenosis
.
J Stroke Cerebrovasc Dis
.
2017
;
26
(
8
):
1760
5
. .
20.
van Veluw
SJ
,
Hilal
S
,
Kuijf
HJ
,
Ikram
MK
,
Xin
X
,
Yeow
TB
,
Cortical microinfarcts on 3T MRI: clinical correlates in memory-clinic patients
.
Alzheimers Dement
.
2015
;
11
(
12
):
1500
9
. .
21.
Hilal
S
,
Chai
YL
,
van Veluw
S
,
Shaik
MA
,
Ikram
MK
,
Venketasubramanian
N
,
Association between subclinical cardiac biomarkers and clinically manifest cardiac diseases with cortical cerebral microinfarcts
.
JAMA Neurol
.
2017
;
74
(
4
):
403
10
. .
22.
Ter Telgte
A
,
Wiegertjes
K
,
Gesierich
B
,
Baskaran
BS
,
Marques
JP
,
Kuijf
HJ
,
Temporal dynamics of cortical microinfarcts in cerebral small vessel disease
.
JAMA Neurol
.
2020
;
77
(
5
):
643
7
. .
23.
Summers
PM
,
Hartmann
DA
,
Hui
ES
,
Nie
X
,
Deardorff
RL
,
McKinnon
ET
,
Functional deficits induced by cortical microinfarcts
.
J Cereb Blood Flow Metab
.
2017
;
37
(
11
):
3599
614
. .
24.
Ter Telgte
A
,
van Leijsen
EMC
,
Wiegertjes
K
,
Klijn
CJM
,
Tuladhar
AM
,
de Leeuw
FE
.
Cerebral small vessel disease: from a focal to a global perspective
.
Nat Rev Neurol
.
2018
;
14
(
7
):
387
98
. .
25.
Brundel
M
,
Reijmer
YD
,
van Veluw
SJ
,
Kuijf
HJ
,
Luijten
PR
,
Kappelle
LJ
,
Cerebral microvascular lesions on high-resolution 7-Tesla MRI in patients with type 2 diabetes
.
Diabetes
.
2014
;
63
(
10
):
3523
9
. .
26.
Pruzin
JJ
,
Schneider
JA
,
Capuano
AW
,
Leurgans
SE
,
Barnes
LL
,
Ahima
RS
,
Diabetes, hemoglobin A1C, and regional Alzheimer disease and infarct pathology
.
Alzheimer Dis Assoc Disord
.
2017
;
31
(
1
):
41
7
. .
27.
Ferro
D
,
van den Brink
H
,
Amier
R
,
van Buchem
M
,
de Bresser
J
,
Bron
E
,
Cerebral cortical microinfarcts: a novel MRI marker of vascular brain injury in patients with heart failure
.
Int J Cardiol
.
2020
;
310
:
96
102
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.